166 related articles for article (PubMed ID: 36449008)
61. Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel.
Heideman DAM; Xu L; Hesselink AT; Doorn S; Ejegod DM; Pedersen H; Quint WGV; Bonde J; Arbyn M
J Clin Virol; 2019 Dec; 121():104201. PubMed ID: 31629967
[TBL] [Abstract][Full Text] [Related]
62. Target-mediated rolling circle transcription coupling with CRISPR/Cas12a-Cas13a for simultaneous detection of HPV16 and HPV18.
Zhou S; Zhu S; Huang Z; Chen J; Li J; Yang M; Jin L; Huo D; Hou C
Chem Commun (Camb); 2023 Oct; 59(80):11987-11990. PubMed ID: 37727048
[TBL] [Abstract][Full Text] [Related]
63. Management of HPV-positive women in cervical screening using results from two consecutive screening rounds.
Polman NJ; Veldhuijzen NJ; Heideman DAM; Snijders PJF; Meijer CJLM; Berkhof J
Int J Cancer; 2019 May; 144(9):2339-2346. PubMed ID: 30565673
[TBL] [Abstract][Full Text] [Related]
64. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
65. Unamplified and Label-Free Detection of HPV16 DNA Using CRISPR-Cas12a-Functionalized Solution-Gated Graphene Transistors.
Zhang H; Deng M; Li Z; Ren Z; Zhang L; Wang M; Jiang S; Yu L; Wang X; Li J
Adv Healthc Mater; 2023 Oct; 12(25):e2300563. PubMed ID: 37377126
[TBL] [Abstract][Full Text] [Related]
66. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
[TBL] [Abstract][Full Text] [Related]
67. A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.
Yang HP; Walmer DK; Merisier D; Gage JC; Bell L; Rangwala S; Shrestha N; Kobayashi L; Eder PS; Castle PE
J Virol Methods; 2011 Sep; 176(1-2):112-4. PubMed ID: 21640138
[TBL] [Abstract][Full Text] [Related]
68. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
69. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
70. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE
BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658
[TBL] [Abstract][Full Text] [Related]
71. [Evaluation of cobas 4800 high-risk HPV test as a tool in cervical cancer screening and cytology triage].
Chen W; Yu LL; Wang H; Fu CJ; Chen F; Cao YQ; Kang LN; Zhang X; Zhao FH; Geng L; Yu L
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):543-8. PubMed ID: 22967475
[TBL] [Abstract][Full Text] [Related]
72. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
[TBL] [Abstract][Full Text] [Related]
73. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
Wu P; Xiong H; Yang M; Li L; Wu P; Lazare C; Cao C; Gao P; Meng Y; Zhi W; Lin S; Hu J; Wei J; Ma D; Liu J; Yin P; Xing H
Gynecol Oncol; 2019 Dec; 155(3):436-443. PubMed ID: 31604662
[TBL] [Abstract][Full Text] [Related]
74. A rapid and sensitive one-pot platform integrating fluorogenic RNA aptamers and CRISPR-Cas13a for visual detection of monkeypox virus.
Wang X; Deng X; Zhang Y; Dong W; Rao Q; Huang Q; Tang F; Shen R; Xu H; Jin Z; Tang Y; Du D
Biosens Bioelectron; 2024 Aug; 257():116268. PubMed ID: 38636316
[TBL] [Abstract][Full Text] [Related]
75. Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening.
Pimple SA; Mishra GA; Deodhar KK
Minerva Ginecol; 2020 Apr; 72(2):96-105. PubMed ID: 32403908
[TBL] [Abstract][Full Text] [Related]
76. A novel rapid visual detection assay for Toxoplasma gondii combining recombinase-aided amplification and lateral flow dipstick coupled with CRISPR-Cas13a fluorescence (RAA-Cas13a-LFD).
Zhao J; Li Y; Xue Q; Zhu Z; Zou M; Fang F
Parasite; 2022; 29():21. PubMed ID: 35420541
[TBL] [Abstract][Full Text] [Related]
77. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of partial genotyping with HPV16/18 for triage of HPV positive, cytology negative women in the COMPACT study.
Hanley SJB; Fujita H; Aoyama-Kikawa S; Kasamo M; Torigoe T; Matsuno Y; Noriaki S;
J Gynecol Oncol; 2021 Nov; 32(6):e86. PubMed ID: 34708593
[TBL] [Abstract][Full Text] [Related]
79. Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.
Hu Z; Yu L; Zhu D; Ding W; Wang X; Zhang C; Wang L; Jiang X; Shen H; He D; Li K; Xi L; Ma D; Wang H
Biomed Res Int; 2014; 2014():612823. PubMed ID: 25136604
[TBL] [Abstract][Full Text] [Related]
80. Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women.
Wang S; He X; Meng F; Pan Q; Zhang L; Zeng J
Biomed Res Int; 2020; 2020():1635324. PubMed ID: 32280677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
